Clinical Outcomes of Noninhibitor Patients with Hemophilia a Switching from Prophylaxis with Factor VIII to Emicizumab: A Meta-Analysis of Real-World Evidence Studies

被引：0
|
作者：
Escobar, Miguel A. [1 ]
Fan, Qi Angela [2 ]
Mokdad, Ali G. [3 ]
Tarantino, Michael D. [4 ]
Burgess, Benjamin [5 ]
Hawe, Emma [5 ]
Fernandez, Maria [6 ]
Bullano, Michael [2 ]
机构：
[1] Univ Texas Hlth Sci Ctr Houston, Div Hematol & Oncol, Dept Med, Houston, TX USA
[2] Takeda Pharmaceut Inc, Lexington, MA USA
[3] Takeda Pharmaceut, Cambridge, MA USA
[4] Univ Illinois, Coll Med, Bleeding & Clotting Disorders Inst, Peoria, IL USA
[5] RTI Hlth Solut, Manchester, Lancs, England
[6] RTI Hlth Solut, Res Triangle Pk, NC USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-178007
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Factor VIII (FVIII) Trough Levels of Real-World Severe-Type People with Hemophilia a (PwHA) on rFVIII-Fc Prophylaxis: Clinical Correlates and Effects on Perceivable Bleeding Outcomes
    Chang, Chia-Yau
    Lai, Shiue-Wei
    Cheng, Mei-Mei
    Liu, Yen-Lin
    Tsai, Jia-Ruey
    Tsai, Chen-Hua
    Ho, Wan-Ling
    Cheng, Chao-Neng
    Hu, Shu-Hsia
    Chen, Yeu-Chin
    BLOOD, 2024, 144 : 3966 - 3967
  • [32] Treatment of male breast cancer: meta-analysis of real-world evidence
    Lin, A. P.
    Huang, T-W
    Tam, K-W
    BRITISH JOURNAL OF SURGERY, 2021, 108 (09) : 1034 - 1042
  • [33] SMART for the treatment of asthma: A network meta-analysis of real-world evidence
    Rogliani, Paola
    Beasley, Richard
    Cazzola, Mario
    Calzetta, Luigino
    RESPIRATORY MEDICINE, 2021, 188
  • [34] Real-World Use of Efanesoctocog Alfa in Adult Patients with Hemophilia a Including Those with a History of Factor VIII Inhibitor
    Parekh, Anya
    Angerman, Cody
    Sanchez, Marvin
    Doan, Nguyenhuong
    Mahajan, Anjlee
    Giermasz, Adam
    BLOOD, 2024, 144 : 2320 - 2321
  • [35] Emicizumab Prophylaxis for the Treatment of Infants with Severe Hemophilia A without Factor VIII Inhibitors: Results from the Interim Analysis of the HAVEN 7 Study
    Pipe, Steven W.
    Collins, Peter
    Dhalluin, Christophe
    Kenet, Gili
    Schmitt, Christophe
    Buri, Muriel
    Jimenez-Yuste, Victor
    Peyvandi, Flora
    Young, Guy
    Oldenburg, Johannes
    Mancuso, Maria Elisa
    Kiialainen, Anna
    Chang, Tiffany
    Lehle, Michaela
    Fijnvandraat, Karin
    BLOOD, 2022, 140
  • [36] Safety of recombinant activated factor VII for treatment of breakthrough bleeds in patients with congenital haemophilia A and inhibitors receiving emicizumab prophylaxis: Review of the real-world evidence
    Kenet, Gili
    Fujii, Teruhisa
    HAEMOPHILIA, 2024, 30 (02) : 267 - 275
  • [37] Efficacy of emicizumab prophylaxis versus factor VIII prophylaxis for treatment of hemophilia A without inhibitors: network meta-analysis and sub-group analyses of the intra-patient comparison of the HAVEN 3 trial
    Reyes, Adriana
    Revir, Cedric
    Niggli, Markus
    Chebon, Sammy
    Schlagmueller, Simone
    Flacke, Jan-Paul
    Zortel, Max
    Paz-Priel, Ido
    Asikanius, Elina
    Hampton, Roger
    Mahajan, Anadi
    Schmidt, Elvira
    Edwards, Susan C.
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (12) : 2079 - 2087
  • [38] ASSOCIATION OF BARIATRIC SURGERY WITH THE RISK OF FRACTURE IN PATIENTS WITH OBESITY: A META-ANALYSIS OF REAL-WORLD EVIDENCE
    Hussain, S.
    Klugarova, J.
    Klugar, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 161 - 161
  • [39] Real-world evidence of direct oral anticoagulants in patients with atrial fibrillation and cancer: A meta-analysis
    Li, Xiuying
    Li, Runkai
    Zhu, Wengen
    Wu, Dexi
    IJC HEART & VASCULATURE, 2024, 55
  • [40] Real-world clinical and economic outcomes from rapid start antiretroviral therapy in HIV: systematic review and meta-analysis
    Duong, Khanh N. C.
    Schmutz, Howard Weston
    Ben-Umeh, Kenechukwu C.
    Duru, Emeka E.
    Rose, Natalie
    Trom, Cassidy
    Chaiyakunapruk, Nathorn
    Willis, Connor
    AIDS, 2025, 39 (03) : 241 - 252
12345